20-63433876-G-C
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2PM5PP2PP3PP5_Moderate
The NM_172107.4(KCNQ2):c.1051C>G(p.Leu351Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L351F) has been classified as Pathogenic.
Frequency
Consequence
NM_172107.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Epilepsy, benign neonatal, 1, and/or myokymia Pathogenic:1
This variant has been previously reported as heterozygous change in multiple related individuals affected with benign familial neonatal epilepsy (PMID: 24375629). Functional studies indicate that the p.Leu351Val variant has a mild to moderate effect on protein function (PMID: 26073431, 24375629). The variant is absent from the ExAC and gnomAD population databases and thus is presumed to be rare. In silico analyses support a deleterious effect of the c.1051C>G (p.Leu351Val) variant on protein function. Based on the available evidence, the c.1051C>G (p.Leu351Val) variant is classified as likely pathogenic. -
Seizures, benign familial neonatal, 1 Other:1
BFNE (benign familial neonatal epilepsy) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at